Pneumonia, Viral: all 156 studies

Page 1 of 2. Open to participants first (13), then studies with results posted, then the rest; newest registration first within each.

• A Study of COVID-19 Vaccine(s) in Children and AdultsRecruitingNCT07798648Phase 3
• A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of AgeRecruitingNCT07730450Phase 4
• Investigation of the Effects of Oxidized Antigens on the T-Cell Response and the Epigenetic Reprogramming of Neutrophils in Lung Diseases - OXIGENE -Not yet recruitingNCT07386912
• A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely ImmunocompromisedRecruitingNCT07013474Phase 3
• Mucosal Associated Invariant T Cell During Viral Pneumonia and Acute Respiratory Distress SyndromeRecruitingNCT06720818
• A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe DiseaseRecruitingNCT06679140Phase 3
• AI-based System for Assessing Suspected Viral Pneumonia Related Lung ChangesRecruitingNCT06501599
• Diagnostic Accuracy of Pocket-size Lung Ultrasound in Pneumonia Etiology and Complications in Hospitalized ChildrenNot yet recruitingNCT06296693Not applicable
• Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BALRecruitingNCT06134492Phase 3
• Discover the Immune Signature of Sepsis Caused by Acute Pulmonary Infection: A Cohort StudyNot yet recruitingNCT05612893
• "Efesovir" (FS-1) for COVID-19, Phase 2Not yet recruitingNCT05060705Phase 2
• Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)RecruitingNCT04790240Phase 1/2
• CardioVascular Disease Progression and Prognosis in COVID-19RecruitingNCT04606732
• Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral InfectionTerminatedNCT06999603Phase 2Results posted
• Stellate Ganglion Block for COVID-induced ParosmiaCompletedNCT06253806Phase 2Results posted
• Study on Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients With Severe COVID-19 Pneumonia.CompletedNCT04878055Phase 3Results posted
• A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC (Phase 1)CompletedNCT04830800Phase 1Results posted
• Effect of Respiratory Exerciser on Pulmonary Functions of COVID-19 PatientsCompletedNCT04826731Results posted
• Pediatric Helmet CPAP Pilot StudyTerminatedNCT04764929Not applicableResults posted
• Inhalation Low Dose Radionuclide Therapy in Treatment COVID-19CompletedNCT04724538Phase 1/2Results posted
• A Trial Looking at the Use of Camostat in People Who Have Tested Positive for Coronavirus (COVID-19) (SPIKE-1)TerminatedNCT04455815Phase 2Results posted
• Efficacy, Safety, Tolerability, and Biomarkers of Ibudilast (MN-166) in Patients Hospitalized With COVID-19 at Risk for ARDSCompletedNCT04429555Phase 2Results posted
• Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe PneumoniaTerminatedNCT04369469Phase 3Results posted
• Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19TerminatedNCT04365101Phase 1/2Results posted
• Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19TerminatedNCT04305457Phase 2Results posted
• Rapid Empiric Treatment With Oseltamivir Study (RETOS)CompletedNCT01248715Phase 4Results posted
• RSV, Influenza, and SARS-CoV-2 Outcomes in Severely Immunosuppressed AdultsActive, not recruitingNCT07816471
• A Study of How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of IbuzatrelvirCompletedNCT07552779Phase 1
• Liver Cirrhosis Patients With Invasive Pulmonary Aspergillosis: in Depth Understanding Clinical Host Risk FactorsActive, not recruitingNCT07238114
• Multiplex PCR for Severe Respiratory Infections During the COVID-19 PandemicCompletedNCT06349707
• Using Probability of Community-Acquired Pneumonia to Tailor Antimicrobials Among InpatientsCompletedNCT05976581Not applicable
• Rehabilitation Treatment of Patients With COVID-19CompletedNCT05808361Not applicable
• Diaphragmatic Echography in COVID-19 PneumoniaCompletedNCT05805579
• The Potential Role of sRAGE, KL-6, and SP-D as Prognostic Factors in Children With COVID-19CompletedNCT05619640
• Study Evaluating Diltiazem in Combination With Standard Treatment in the Management of Patients Hospitalized With COVID-19 PneumoniaWithdrawnNCT05563168Phase 2
• A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19WithdrawnNCT05545319Phase 2
• Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 PneumoniaTerminatedNCT05531149Phase 3
• Study of the Use of the Drug Ingaron in Patients With COVID-19CompletedNCT05386459
• Tobacco Use and the Risk of COVID-19 and Adverse OutcomesCompletedNCT05321433
• Evaluation of Postmortem Pulmonary Interstitial Fibrosis Severity and EGFR Positivity in Covid-19 PneumoniaCompletedNCT05290441Not applicable
• Mesenchymal Stromal Cells for COVID-19 and Viral PneumoniasWithdrawnNCT05286255Phase 1
• Comparison Between Different Doses of Steroids in COVID-19 PatientsCompletedNCT05279482
• D-Dimer as Predictor of Disease Outcome in Intensive Care Unit in COVID-19m PatientsCompletedNCT05279469
• Health Communication to Influence COVID-19 Vaccination Intent and Message PropagationCompletedNCT05244356Not applicable
• Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia.Active, not recruitingNCT05123755Phase 2
• Randomized-controlled Trial of the Effectiveness of COVID-19 Early Treatment in CommunityCompletedNCT05087381Phase 4
• Cromolyn Sodium for Treatment of COVID-19 PneumoniaTerminatedNCT05077917Phase 3
• Steroid and Anticoagulant Therapy in covid19CompletedNCT05021588Not applicable
• Yinhu Qingwen Granule in the Treatment of Viral PneumoniaStatus unknownNCT04955223Early Phase 1
• Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)Status unknownNCT04952337
• Characteristics of Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection (COVID-19)Status unknownNCT04948242
• IRAK 4 Inhibitor (PF-06650833) in Hospitalized Patients With COVID-19 Pneumonia and Exuberant Inflammation.Status unknownNCT04933799Phase 2
• Impact of Severe Acute Respiratory Syndrome (SARS-CoV-2/COVID-19) Related Pneumonia on Lung Function and Structure.Status unknownNCT04916834
• Effectiveness of Covid-19 Vaccination in Eswatini Against SARS-CoV-2 Associated Hospitalization and DeathCompletedNCT04914832Phase 4
• Pilot Study for Cyproheptadine in Hospitalized Patient for COVID-19Status unknownNCT04876573Phase 2
• DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 PneumoniaStatus unknownNCT04836780Phase 3
• Hemodynamic Effect of Prone Position in Non-intubated Patient With COVID 19Status unknownNCT04834947
• Spironolactone and Dexamethasone in Patients Hospitalized With COVID-19Status unknownNCT04826822Phase 3
• Vascular Abnormalities Detected With Chest CT in COVID-19Status unknownNCT04824313
• Cyproheptadine in Severe COVID-19 : A Unblinded Randomized TrialStatus unknownNCT04820751Phase 3
• Association Between Body Mass Index and HFNC Therapy SuccessCompletedNCT04799132
• Initial CT Findings and CO-RADS Stage in COVID-19CompletedNCT04789447
• Severe Acute Respiratory Infection - Preparedness (COVID-19 and Influenza)Status unknownNCT04786301
• Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in ThailandCompletedNCT04764422Phase 1/2
• Remdesivir in Adults With Covid-19: Mansoura University Hospital ExperienceStatus unknownNCT04728880
• Antiviral Drugs on the Treatment of SARS-CoV-2CompletedNCT04727775
• Nebulized Heparin for the Treatment of COVID-19CompletedNCT04723563Phase 4
• TranSfUsion of coNvalescent plAsma for the Early Treatment of pneuMonIa in COVID-19 PatientsCompletedNCT04716556Not applicable
• Aralast NP With Antiviral Treatment and Standard of Care Versus Antiviral Treatment With Standard of Care in Hospitalized Patients With Pneumonia and COVID-19 InfectionWithdrawnNCT04675086Phase 3
• Circulatory Coherence in COVID-19 and Non-COVID-19 Patients With SepsisCompletedNCT04644302
• Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 SubjectsCompletedNCT04629703Phase 3
• Characteristics of COVID-19 Patients in Kazakhstan in Early 2020Status unknownNCT04627194
• Biomarkers for Dexamethasone Response in Sars-Cov-2 / COVID-19 PneumoniaTerminatedNCT04619693
• Inhaled NO for the Treatment of Viral Pneumonia in AdultsCompletedNCT04606407Not applicable
• Ivermectin in Adults With Severe COVID-19.TerminatedNCT04602507Phase 2
• Risk Factors and Computed Tomography Findings in COVID-19.CompletedNCT04577105
• Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19CompletedNCT04570254Not applicable
• Nitazoxanide Therapy for Patients With COVID-19 PneumoniaCompletedNCT04561219Phase 2
• Safety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19CompletedNCT04550325Phase 1/2
• Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 InfectionStatus unknownNCT04528888Phase 3
• Toclizumam Versus Dexamethasone in Severe Covid-19 CasesCompletedNCT04519385Not applicable
• Prone Position and Respiratory Outcomes in Non-Intubated COVID-19 PatiEnts The "PRONE" StudyCompletedNCT04517123Not applicable
• Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated DeliriumWithdrawnNCT04513314Phase 4
• Obesity Surgery During 2020 Italian PandemicStatus unknownNCT04480034
• Assessment of the Risk of Pulmonary Embolism and Coagulation Profile in Patients With COVID-19 Lung DiseaseCompletedNCT04479540Not applicable
• Nitric Oxide Therapy for COVID-19 Patients With Oxygen RequirementCompletedNCT04476992Phase 1/2
• COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected PatientsStatus unknownNCT04474340Phase 1
• Characteristics of Patients With COVID-19 in Meta State, ColombiaWithdrawnNCT04456426
• Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (CANADA Trial)WithdrawnNCT04456088Phase 2
• Anti Infective Agents Impact in COVID-19 PneumoniaCompletedNCT04453501
• Glycine Supplement for Severe COVID-19TerminatedNCT04443673Not applicable
• Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19)CompletedNCT04435327
• HFNC Treatment in COVID-19 PneumoniaCompletedNCT04424836
• Ultrasonography in Norwegian Emergency Department Patients With Suspected Covid-19 InfectionTerminatedNCT04422691
• Characterization of Persistent Pulmonary Abnormalities Following COVID-19 PneumoniaCompletedNCT04422613Not applicable
• Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19CompletedNCT04420247Phase 3
• Convalescent Antibodies Infusion in COVID 19 PatientsWithdrawnNCT04418531Not applicable
• Low Dose Pulmonary Irradiation in Patients With COVID-19 Infection of Bad PrognosisStatus unknownNCT04414293Not applicable
• High Versus Low LMWH Dosages in Hospitalized Patients With Severe COVID-19 Pneumonia and CoagulopathyStatus unknownNCT04408235Phase 3
• Predictive Models for Intensive Care Admission and Death of COVID-19Status unknownNCT04401228

← Pneumonia, Viral overview